EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring angiogenic pathways in breast cancer: Clinicopathologic correlations and prognostic implications based on gene expression profiles from a large-scale genomic dataset

Nehad M Ayoub iD, Salam Sardiah iD, Qusai Y Al-Share iD, Mohammad S Alkader

PLOS ONE · 20.09.2024 · 19 (9) · e0310557

DOI: 10.1371/journal.pone.0310557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 20.09.2024. Verfasst von Nehad M Ayoub und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan. Hauptthemen laut MEDLINE: Breast Neoplasms, Neovascularization, Pathologic, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Research, Jordan University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Angiogenesis inhibitors targeting VEGF, or its receptors have consistently produced disappointing clinical outcomes in breast cancer. Therefore, there is an urgent need to explore alternative angiogenic pathways in breast cancer. This study aimed to describe the gene expression of pivotal pro-angiogenic genes in breast cancer and to further analyze the associations with the clinicopathologic tumor features, prognostic factors, and overall survival. Such findings would expand the understanding of the role of different angiogenic pathways in breast cancer pathogenesis and identify patients at risk of more aggressive disease who could be eligible for intense treatment regimens. Additionally, exploring angiogenic pathways helps identify new potential drug targets for breast cancer.

Methods

The mRNA expression levels for eight pro-angiogenic genes [ VEGFA , HGF , FGF1 , FGF2 , ANGPT1 , ANGPT2 , PDGFA , and PDGFB ] were obtained from the METABRIC (Molecular Taxonomy of Breast Cancer International Consortium) dataset available at cBioPortal public domain. Pertinent demographic and tumor information were retrieved.

Results

VEGFA and ANGPT2 genes had the highest expression levels with average mRNA log intensities of 7.18±0.7 and 7.11±0.53, respectively. VEGFA expression was not correlated with the expression of other pro-angiogenic genes, the clinicopathologic tumor features, and the overall survival of patients. FGF1 , ANGPT1 , and PDGFA mRNA levels were negatively correlated with the age of patients at diagnosis. The expression of FGF1 and FGF2 correlated inversely with tumor size and the Nottingham Prognostic Index (p = 0.03 and p = 0.002, respectively). Expression of HGF was significantly associated with advanced tumor stage (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeovascularization, PathologicGene Expression Regulation, NeoplasticHumansFemalePrognosisMiddle AgedVascular Endothelial Growth Factor ATranscriptomeAngiopoietin-2AdultAgedGenomicsGene Expression ProfilingFibroblast Growth Factor 1Platelet-Derived Growth FactorAngiopoietin-1Fibroblast Growth Factor 2

Substanzen

Vascular Endothelial Growth Factor AANGPT1 protein, humanAngiopoietin-2ANGPT2 protein, humanFibroblast Growth Factor 1Platelet-Derived Growth FactorAngiopoietin-1VEGFA protein, humanFibroblast Growth Factor 2

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
  • Department of Medical Oncology, Military Cancer Center, Jordanian Royal Medical Services, Amman, Jordan.

ORCID-Profile: Nehad M Ayoub, Salam Sardiah, Qusai Y Al-Share

Förderung

  • Deanship of Research, Jordan University of Science and Technology

Zitieren

APA

Ayoub, N. M., Sardiah, S., Al-Share, Q. Y., & Alkader, M. S. (2024). Exploring angiogenic pathways in breast cancer: Clinicopathologic correlations and prognostic implications based on gene expression profiles from a large-scale genomic dataset. PLOS ONE, 19(9), e0310557. https://doi.org/10.1371/journal.pone.0310557

Vancouver

Ayoub NM, Sardiah S, Al-Share QY, Alkader MS. Exploring angiogenic pathways in breast cancer: Clinicopathologic correlations and prognostic implications based on gene expression profiles from a large-scale genomic dataset. PLOS ONE. 2024;19(9):e0310557. doi:10.1371/journal.pone.0310557

BibTeX
@article{Ayoub2024,
  author = {Ayoub, Nehad M and Sardiah, Salam and Al-Share, Qusai Y and Alkader, Mohammad S},
  title = {Exploring angiogenic pathways in breast cancer: Clinicopathologic correlations and prognostic implications based on gene expression profiles from a large-scale genomic dataset},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {9},
  pages = {e0310557},
  doi = {10.1371/journal.pone.0310557}
}
Kostenlos starten →